Preclinical and clinical evidence of nephro- and cardiovascular protective effects of glycosaminoglycans (original) (raw)
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Arrigo Cicero
International journal of nephrology and renovascular disease, 2010
View PDFchevron_right
Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats
Giovanni Gambaro
Kidney International, 1992
View PDFchevron_right
Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy
Giovanni Gambaro
Kidney International, 1994
View PDFchevron_right
The Role of Sulodexide in the Treatment of Diabetic Nephropathy
Robert Niecestro
Drugs, 2007
View PDFchevron_right
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects
Giovanni Gambaro
International angiology : a journal of the International Union of Angiology, 2014
View PDFchevron_right
Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy
David Packham
Journal of the American Society of Nephrology, 2012
View PDFchevron_right
The Heparanase Inhibitor (Sulodexide) Decreases Urine Glycosaminoglycan Excretion and Mitigates Functional and Histological Renal Damages in Diabetic Rats
jamal khalilpour
Acta Medica Bulgarica, 2019
View PDFchevron_right
Efficacy of low-dose oral sulodexide in the management of diabetic nephropathy
Ben Baya Brahim
Journal of nephrology
View PDFchevron_right
Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria
Bancha Satirapoj
Journal of Diabetes Research, 2020
View PDFchevron_right
The effects of the therapy with natural glycosaminoglycans (Sulodexide) on proteinuria in different types of glomerulonephritis
Ligia Petrica
Facta Universitatis, …, 2001
View PDFchevron_right
Sulfated glycosaminoglycans restore glycocalyx barrier properties of cultured endothelial cells in hyperglycemia
Lysette Broekhuizen
The FASEB Journal, 2008
View PDFchevron_right
Urinary excretion of glycosaminoglycans and albumin in experimental diabetes mellitus
Y. Michelacci
Glycobiology, 2000
View PDFchevron_right
The Protective Role of Fucosylated Chondroitin Sulfate, a Distinct Glycosaminoglycan, in a Murine Model of Streptozotocin-Induced Diabetic Nephropathy
Christina Takiya
PLoS ONE, 2014
View PDFchevron_right
Oral Sulodexide Reduces Albuminuria in Microalbuminuric and Macroalbuminuric Type 1 and Type 2 Diabetic Patients
Domenico Fedele
Journal of the American Society of Nephrology, 2002
View PDFchevron_right
Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression
Maria Gorska
Diabetes/Metabolism Research and Reviews, 2008
View PDFchevron_right
Effect of Sulodexide on Urinary Biomarkers of Kidney Injury in Normoalbuminuric Type 2 Diabetes: A Randomized Controlled Trial
Prajej Ruangkanchanasetr
Journal of Diabetes Research, 2015
View PDFchevron_right
No Change in Glomerular Heparan Sulfate Structure in Early Human and Experimental Diabetic Nephropathy
Jo Berden
Journal of Biological Chemistry, 2006
View PDFchevron_right
Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus
Lysette Broekhuizen
Diabetologia, 2010
View PDFchevron_right
Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis
Tom Nijenhuis
Frontiers in Molecular Biosciences, 2023
View PDFchevron_right
Sulodexide for Kidney Protection in Type 2 Diabetes Patients With Microalbuminuria: A Randomized Controlled Trial
Robert Atkins
American Journal of Kidney Diseases, 2011
View PDFchevron_right
Efficacy of long-term low-dose sulodexide in diabetic and non-diabetic nephropathies
Diana Zilisteanu
Romanian Journal Of Internal Medicine, 2015
View PDFchevron_right
Glycosaminoglycan treatment in glomerulonephritis? An interesting option to investigate
Norella Kong
Journal of nephrology
View PDFchevron_right
Regulation of Glomerular Endothelial Cell Proteoglycans by Glucose
Tae-sun Ha
Journal of Korean Medical Science, 2004
View PDFchevron_right
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition
Giovanni Gambaro
Journal of Translational Medicine, 2012
View PDFchevron_right
Glycosyl albumin and diabetic microalbuminuria: Demonstration of an altered renal handling
Giovanni Candiano
Kidney International, 1984
View PDFchevron_right
Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy
David Packham
Diabetic Medicine, 2007
View PDFchevron_right